|
1
|
Muggia F: Platinum compounds 30 years
after the introduction of cisplatin: implications for the treatment
of ovarian cancer. Gynecol Oncol. 112:275–281. 2009.PubMed/NCBI
|
|
2
|
Florea AM and Büsselberg D: Cisplatin as
an anti-tumor drug: cellular mechanisms of activity, drug
resistance and induced side effects. Cancers (Basel). 3:1351–1371.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Galluzzi L, Senovilla L, Vitale I, Michels
J, Martins I, Kepp O, Castedo M and Kroemer G: Molecular mechanisms
of cisplatin resistance. Oncogene. 31:1869–1883. 2012. View Article : Google Scholar
|
|
4
|
Eastman A: The formation, isolation and
characterization of DNA adducts produced by anticancer platinum
complexes. Pharmacol Ther. 34:155–166. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Woźniak K and Błasiak J: Recognition and
repair of DNA-cisplatin adducts. Acta Biochim Pol. 49:583–596.
2002.
|
|
6
|
Basu A and Krishnamurthy S: Cellular
responses to Cisplatin-induced DNA damage. J Nucleic Acids.
2010:pii: 201367. 2010. View Article : Google Scholar
|
|
7
|
Mandic A, Hansson J, Linder S and Shoshan
MC: Cisplatin induces endoplasmic reticulum stress and
nucleus-independent apoptotic signaling. J Biol Chem.
278:9100–9106. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu H and Baliga R: Endoplasmic reticulum
stress-associated caspase 12 mediates cisplatin-induced LLC-PK1
cell apoptosis. J Am Soc Nephrol. 16:1985–1992. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peyrou M, Hanna PE and Cribb AE:
Cisplatin, gentamicin, and p-aminophenol induce markers of
endoplasmic reticulum stress in the rat kidneys. Toxicol Sci.
99:346–353. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu F, Megyesi J and Price PM: Cytoplasmic
initiation of cisplatin cytotoxicity. Am J Physiol Renal Physiol.
295:F44–F52. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Berridge MJ: The endoplasmic reticulum: a
multifunctional signaling organelle. Cell Calcium. 32:235–249.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jørgensen MM, Bross P and Gregersen N:
Protein quality control in the endoplasmic reticulum. APMIS Suppl.
109:86–91. 2003.
|
|
13
|
Rao RV, Ellerby HM and Bredesen DE:
Coupling endoplasmic reticulum stress to the cell death program.
Cell Death Differ. 11:372–380. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim R, Emi M, Tanabe K and Murakami S:
Role of the unfolded protein response in cell death. Apoptosis.
11:5–13. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Benbrook DM and Long A: Integration of
autophagy, proteasomal degradation, unfolded protein response and
apoptosis. Exp Oncol. 34:286–297. 2012.PubMed/NCBI
|
|
16
|
Høyer-Hansen M and Jäättelä M: Connecting
endoplasmic reticulum stress to autophagy by unfolded protein
response and calcium. Cell Death Differ. 14:1576–1582.
2007.PubMed/NCBI
|
|
17
|
Yu H, Su J, Xu Y, Kang J, Li H, Zhang L,
Yi H, Xiang X, Liu F and Sun L: p62/SQSTM1 involved in cisplatin
resistance in human ovarian cancer cells by clearing ubiquitinated
proteins. Eur J Cancer. 47:1585–1594. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu Y, Yu H, Qin H, Kang J, et al:
Inhibition of autophagy enhances cisplatin cytotoxicity through
endoplasmic reticulum stress in human cervical cancer cells. Cancer
Lett. 314:232–243. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhong JT, Xu Y, Yi HW, et al: The BH3
mimetic S1 induces autophagy through ER stress and disruption of
Bcl-2/Beclin 1 interaction in human glioma U251 cells. Cancer Lett.
323:180–187. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu N, Xu Y, Sun JT, et al: The BH3
mimetic S1 induces endoplasmic reticulum stress-associated
apoptosis in cisplatin-resistant human ovarian cancer cells
although it activates autophagy. Oncol Rep. 30:2677–2684. 2013.
|
|
21
|
Fenteany G, Standaert RF, Lane WS, Choi S,
Corey EJ and Schreiber SL: Inhibition of proteasome activities and
subunit-specific amino-terminal threonine modification by
lactacystin. Science. 268:726–731. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Craiu A, Gaczynska M, Akopian T, et al:
Lactacystin and clasto-lactacystin beta-lactone modify multiple
proteasome beta-subunits and inhibit intracellular protein
degradation and major histocompatibility complex class I antigen
presentation. J Biol Chem. 272:13437–13445. 1997. View Article : Google Scholar
|
|
23
|
Ostrowska H, Wojcik C, Omura S and
Worowski K: Lactacystin, a specific inhibitor of the proteasome,
inhibits human platelet lysosomal cathepsin A-like enzyme. Biochem
Biophys Res Commun. 234:729–732. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Geier E, Pfeifer G, Wilm M, et al: A giant
protease with potential to substitute for some functions of the
proteasome. Science. 283:978–981. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rebillard A, Lagadic-Gossmann D and
Dimanche-Boitrel MT: Cisplatin cytotoxicity: DNA and plasma
membrane targets. Curr Med Chem. 15:2656–2663. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ogata M, Hino S, Saito A, Morikawa K, et
al: Autophagy is activated for cell survival after endoplasmic
reticulum stress. Mol Cell Biol. 26:9220–9231. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin X, Li S, Zhao Y, Ma X, Zhang K, He X
and Wang Z: Interaction domains of p62: a bridge between p62 and
selective autophagy. DNA Cell Biol. 32:220–227. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tanida I: Autophagosome formation and
molecular mechanism of autophagy. Antioxid Redox Signal.
14:2201–2214. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Szegezdi E, Logue SE, Gorman AM and Samali
A: Mediators of endoplasmic reticulum stress-induced apoptosis.
EMBO Rep. 7:880–885. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tabas I and Ron D: Integrating the
mechanisms of apoptosis induced by endoplasmic reticulum stress.
Nat Cell Biol. 13:184–190. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Olive PL and Banáth JP: Kinetics of
H2AX phosphorylation after exposure to cisplatin.
Cytometry B Clin Cytom. 76:79–90. 2009.
|
